Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice

Am J Physiol Endocrinol Metab. 2012 Aug 1;303(3):E377-88. doi: 10.1152/ajpendo.00641.2011. Epub 2012 May 22.

Abstract

Obstructive sleep apnea (OSA) induces intermittent hypoxia (IH) during sleep and is associated with elevated triglycerides (TG). We previously demonstrated that mice exposed to chronic IH develop elevated TG. We now hypothesize that a single exposure to acute hypoxia also increases TG due to the stimulation of free fatty acid (FFA) mobilization from white adipose tissue (WAT), resulting in increased hepatic TG synthesis and secretion. Male C57BL6/J mice were exposed to FiO(2) = 0.21, 0.17, 0.14, 0.10, or 0.07 for 6 h followed by assessment of plasma and liver TG, glucose, FFA, ketones, glycerol, and catecholamines. Hypoxia dose-dependently increased plasma TG, with levels peaking at FiO(2) = 0.07. Hepatic TG levels also increased with hypoxia, peaking at FiO(2) = 0.10. Plasma catecholamines also increased inversely with FiO(2). Plasma ketones, glycerol, and FFA levels were more variable, with different degrees of hypoxia inducing WAT lipolysis and ketosis. FiO(2) = 0.10 exposure stimulated WAT lipolysis but decreased the rate of hepatic TG secretion. This degree of hypoxia rapidly and reversibly delayed TG clearance while decreasing [(3)H]triolein-labeled Intralipid uptake in brown adipose tissue and WAT. Hypoxia decreased adipose tissue lipoprotein lipase (LPL) activity in brown adipose tissue and WAT. In addition, hypoxia decreased the transcription of LPL, peroxisome proliferator-activated receptor-γ, and fatty acid transporter CD36. We conclude that acute hypoxia increases plasma TG due to decreased tissue uptake, not increased hepatic TG secretion.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Dietary Fats / pharmacokinetics
  • Emulsions / administration & dosage
  • Emulsions / pharmacokinetics
  • Fat Emulsions, Intravenous / pharmacokinetics
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / etiology*
  • Hypertriglyceridemia / metabolism
  • Hypoxia / blood
  • Hypoxia / complications*
  • Hypoxia / metabolism*
  • Lipolysis / drug effects
  • Male
  • Metabolic Clearance Rate / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Oxygen / pharmacology
  • Phospholipids / administration & dosage
  • Phospholipids / pharmacokinetics
  • Soybean Oil / administration & dosage
  • Soybean Oil / pharmacokinetics
  • Triglycerides / blood
  • Triglycerides / metabolism*
  • Triolein / administration & dosage
  • Triolein / pharmacokinetics
  • Up-Regulation / drug effects

Substances

  • Dietary Fats
  • Emulsions
  • Fat Emulsions, Intravenous
  • Phospholipids
  • Triglycerides
  • soybean oil, phospholipid emulsion
  • Triolein
  • Soybean Oil
  • Oxygen